Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22. - Wikidata - wikimedia - TriplyDB

Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.

Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.

http://www.wikidata.org/entity/Q37277272

about

Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma.Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis.Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma

P2860

Q39021344-3A6DC30C-4491-4212-A295-6BC941FB5B3E Q47840579-A66DAEE6-14EC-4C1E-9B19-A4A68FA00D19 Q58760715-6485931B-72EC-4B48-B73E-A45081CCD355

P2860

Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22.

http://www.wikidata.org/entity/Q37277272

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cyclosporine A immunosuppressi ...... cell carcinoma through IL-22.

@en

Cyclosporine A immunosuppressi ...... cell carcinoma through IL-22.

@nl

type

label

Cyclosporine A immunosuppressi ...... cell carcinoma through IL-22.

@en

Cyclosporine A immunosuppressi ...... cell carcinoma through IL-22.

@nl

prefLabel

Cyclosporine A immunosuppressi ...... cell carcinoma through IL-22.

@en

Cyclosporine A immunosuppressi ...... cell carcinoma through IL-22.

@nl

P1433

Q37277272-3DF82C14-7A9A-46E8-ADD6-414228D54DC3

P1476

Q37277272-2C371C01-9AA5-4431-ABC3-36CDC886F01C

P2093

Q37277272-1A18E746-638C-47B5-84CB-A15A2BDAD832

Q37277272-201EF796-C5DA-4046-AA2F-A9572D60601A

Q37277272-36C4D08D-D927-470D-8C44-D68686C4E8CF

Q37277272-37DE22BD-907E-4BA9-BD2A-8A9D4C9758D0

Q37277272-408AEC5B-120E-4C11-B4F0-E80235E10222

Q37277272-5D42D962-6A88-46CE-A68B-AC0772B2A080

Q37277272-64F5A9F9-B4FA-440E-AAA2-2B98CE778217

Q37277272-B48417C6-9FE6-4265-BA5F-100C28170958

Q37277272-F38DAB7D-4839-470F-AFAE-6BC7F17A6E45

Q37277272-F58830CA-09A2-442F-968E-88391B305DAD

P2860

Q37277272-005C8100-CFF8-4461-81DD-3161FBF5FBB8

Q37277272-058465D0-F64A-49FA-B53B-F22AFDBFE3ED

Q37277272-06F89917-1E26-4D68-82BD-E2D7CF9F8890

Q37277272-08D4A69E-8CE3-457E-8105-DA7C5C41ADBF

Q37277272-0A38799C-42D6-423C-A80E-8E10B7B63486

Q37277272-0E5B9DF9-1356-42C7-AF56-CADEAB0D0834

Q37277272-1DADEFB6-305D-424E-B21F-EFEEE0E2A990

Q37277272-1FC0268B-0319-46EE-9CD1-51237E2D51E8

Q37277272-253AC35B-9B91-49CE-868C-473DCE21173E

Q37277272-291C421C-A19B-4CF1-A892-E7A14660C5BD

P304

Q37277272-204A3461-8A75-427B-B356-4A26E9F95788

P31

Q37277272-C0A46428-B598-4E2E-A47C-9F6570E0B4CD

P356

Q37277272-A673F7D5-9ACF-4C0C-9E3A-9331EA97B331

P433

Q37277272-396B7335-3EEF-4D7A-8972-2A302DDC4E09

P478

Q37277272-4E156EC1-3D03-417C-B54E-E1CB4DC3A930

P50

Q37277272-7EB932A0-BBB4-4443-A923-BC6FB78076AF

Q37277272-A431C9C9-AC16-4960-A85A-4D66CBA4B2A9

P577

Q37277272-ABAD6151-F2A3-4EA5-B3F6-AF1F80531FE8

P698

Q37277272-103E1CD2-E665-47D0-BF38-CFD2DB18C186

P921

Q37277272-A818CB2D-4FDE-42AC-9704-C49C761FC74C

P932

Q37277272-32B7F5B0-C687-4FFC-B88A-11FA3B77FC43

P356

JCI.INSIGHT.86434

P1433

P1476

Cyclosporine A immunosuppressi ...... cell carcinoma through IL-22.

@en

P2093

Channa Ovits

http://www.w3.org/2001/XMLSchema#string

Diane Felsen

http://www.w3.org/2001/XMLSchema#string

Hiroshi Mitsui

http://www.w3.org/2001/XMLSchema#string

James G Krueger

http://www.w3.org/2001/XMLSchema#string

Juana Gonzalez

http://www.w3.org/2001/XMLSchema#string

Kathleen L Tober

http://www.w3.org/2001/XMLSchema#string

Nazanin Roudiani

http://www.w3.org/2001/XMLSchema#string

Tatiana M Oberyszyn

http://www.w3.org/2001/XMLSchema#string

Teddy Bryan

http://www.w3.org/2001/XMLSchema#string

Valerie Yanofsky

http://www.w3.org/2001/XMLSchema#string

P2860

The roles of IFN gamma in protection against tumor development and cancer immunoediting

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data

Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer.

Clinicopathologic variants of cutaneous squamous cell carcinoma.

Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naïve T cells into cytokine-producing mature T cells.

Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.

P304

e86434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI.INSIGHT.86434

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Melody Abikhair Burgo

P577

2016-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27699266

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

5033893

http://www.w3.org/2001/XMLSchema#string